GLOBUS MED INC's ticker is GMED and the CUSIP is 379577208. A total of 362 filers reported holding GLOBUS MED INC in Q2 2022. The put-call ratio across all filers is 0.16 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $18,700,970 | +22.9% | 376,656 | +47.4% | 0.00% | 0.0% |
| Q2 2023 | $15,218,485 | -30.2% | 255,601 | -33.6% | 0.00% | 0.0% |
| Q1 2023 | $21,814,611 | +48.6% | 385,145 | +94.9% | 0.00% | 0.0% |
| Q4 2022 | $14,676,271 | +11.8% | 197,607 | -10.3% | 0.00% | 0.0% |
| Q3 2022 | $13,124,000 | +9.5% | 220,298 | +3.2% | 0.00% | +100.0% |
| Q2 2022 | $11,980,000 | -34.3% | 213,390 | -13.7% | 0.00% | -50.0% |
| Q1 2022 | $18,244,000 | +29.9% | 247,266 | +27.1% | 0.00% | +100.0% |
| Q4 2021 | $14,048,000 | -0.2% | 194,552 | +5.9% | 0.00% | 0.0% |
| Q3 2021 | $14,071,000 | -7.1% | 183,644 | -6.0% | 0.00% | -50.0% |
| Q2 2021 | $15,145,000 | +5.8% | 195,351 | -15.8% | 0.00% | 0.0% |
| Q1 2021 | $14,315,000 | +17.9% | 232,131 | +24.7% | 0.00% | 0.0% |
| Q4 2020 | $12,145,000 | -22.9% | 186,214 | -41.4% | 0.00% | 0.0% |
| Q3 2020 | $15,747,000 | -17.8% | 318,024 | -20.8% | 0.00% | -33.3% |
| Q2 2020 | $19,146,000 | +37.2% | 401,299 | +22.3% | 0.00% | 0.0% |
| Q1 2020 | $13,953,000 | +4.4% | 328,075 | +44.6% | 0.00% | +50.0% |
| Q4 2019 | $13,361,000 | +10.3% | 226,942 | -4.2% | 0.00% | 0.0% |
| Q3 2019 | $12,113,000 | +18.5% | 236,949 | -1.9% | 0.00% | 0.0% |
| Q2 2019 | $10,220,000 | -9.8% | 241,615 | +5.4% | 0.00% | 0.0% |
| Q1 2019 | $11,331,000 | +14.7% | 229,321 | +0.5% | 0.00% | 0.0% |
| Q4 2018 | $9,875,000 | -25.9% | 228,153 | -2.8% | 0.00% | 0.0% |
| Q3 2018 | $13,319,000 | -8.0% | 234,639 | -18.3% | 0.00% | 0.0% |
| Q2 2018 | $14,484,000 | -37.5% | 287,022 | -38.3% | 0.00% | -50.0% |
| Q1 2018 | $23,182,000 | +13.8% | 465,316 | -6.1% | 0.00% | +33.3% |
| Q4 2017 | $20,372,000 | -7.3% | 495,678 | -33.0% | 0.00% | 0.0% |
| Q3 2017 | $21,977,000 | +24.8% | 739,450 | +39.2% | 0.00% | -25.0% |
| Q2 2017 | $17,616,000 | +2.9% | 531,376 | -8.1% | 0.00% | +33.3% |
| Q1 2017 | $17,125,000 | +40.2% | 578,179 | +17.5% | 0.00% | 0.0% |
| Q4 2016 | $12,211,000 | +13.3% | 492,146 | +3.1% | 0.00% | +50.0% |
| Q3 2016 | $10,774,000 | -24.3% | 477,350 | -20.0% | 0.00% | -33.3% |
| Q2 2016 | $14,224,000 | +1.1% | 596,871 | +0.8% | 0.00% | 0.0% |
| Q1 2016 | $14,068,000 | -26.6% | 592,350 | -14.0% | 0.00% | -40.0% |
| Q4 2015 | $19,161,000 | +37.7% | 688,761 | +2.2% | 0.01% | +66.7% |
| Q3 2015 | $13,918,000 | +118.6% | 673,687 | +171.7% | 0.00% | +50.0% |
| Q2 2015 | $6,366,000 | +416.7% | 247,993 | +407.9% | 0.00% | – |
| Q1 2015 | $1,232,000 | -60.5% | 48,826 | -62.8% | 0.00% | -100.0% |
| Q4 2014 | $3,121,000 | +8.1% | 131,315 | -10.5% | 0.00% | 0.0% |
| Q3 2014 | $2,887,000 | -49.6% | 146,765 | -38.7% | 0.00% | -50.0% |
| Q2 2014 | $5,723,000 | +14.8% | 239,268 | +27.6% | 0.00% | 0.0% |
| Q1 2014 | $4,986,000 | -6.9% | 187,503 | -29.3% | 0.00% | 0.0% |
| Q4 2013 | $5,355,000 | +22.2% | 265,385 | +5.7% | 0.00% | 0.0% |
| Q3 2013 | $4,382,000 | -23.3% | 250,977 | -26.0% | 0.00% | 0.0% |
| Q2 2013 | $5,715,000 | – | 338,948 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 589,100 | $45,137,000 | 24.71% |
| Sterling Investment Advisors, Ltd. | 188,123 | $14,414,000 | 4.29% |
| Godshalk Welsh Capital Management, Inc. | 73,748 | $5,651,000 | 3.52% |
| Pembroke Management, LTD | 601,447 | $46,083,000 | 3.47% |
| Integral Health Asset Management, LLC | 150,000 | $11,493,000 | 3.30% |
| XXEC, Inc. | 51,925 | $3,978,000 | 3.03% |
| PARADIGM CAPITAL MANAGEMENT INC/NY | 615,000 | $47,122,000 | 2.42% |
| Van Berkom & Associates Inc. | 946,997 | $72,559,000 | 2.20% |
| RTW INVESTMENTS, LP | 1,670,811 | $128,018,000 | 1.93% |
| Sivik Global Healthcare LLC | 95,000 | $7,279,000 | 1.74% |